Corcept Endocrinology President Sean Maduck sells $2.89 million in Corcept Therapeutics shares

CORT•2026-10-05

Sean Maduck exercised options for 25,000 Corcept Therapeutics shares at $8.27 and sold 25,000 shares for weighted average prices ranging from $115.5373 to $116.5534 on Oct. 1-2, 2026.

1. Transactions and holdings

Maduck directly held 9,938 shares and 41,986 stock options following the transactions.

Sources

Corcept Endocrinology President Sean Maduck sells $2.89 million in Corcept Therapeutics shares

Sec

Corcept Endocrinology President Sean Maduck sells $2.89 million in Corcept Therapeutics shares

1. Transactions and holdings

Related News

KKR to buy fund administrator Gen II in $5.1 billion deal including debt

Ross Stores director Christian B. Johnson files initial beneficial ownership statement

KKR to acquire Gen II Fund Services for more than $5 billion from Hg and General Atlantic

Sources

Corcept Endocrinology President Sean Maduck sells $2.89 million in Corcept Therapeutics shares

USANA Health Sciences enters first amendment to credit agreement on Sept. 30, 2026

Accenture contractor removed from FBI following damaging data breach, sources say